ziftomenib: a menin inhibitor for r/r npm1-mutated aml
Published 10 months ago • 379 plays • Length 3:55Download video MP4
Download video MP3
Similar videos
-
1:41
the emerging role of menin inhibitors in the treatment of npm1-mutated and kmt2a-rearranged r/r aml
-
1:38
lba: komet-001 - ziftomenib monotherapy in r/r npm1-mutated aml
-
3:17
ziftomenib: mechanism of action and promising results in patients with kmt2ar or npm1m aml
-
1:14
promising novel agents in aml: menin inhibitors
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
1:09
menin inhibitors for the treatment of aml: insights into the covalent-101 trial
-
2:51
komet-008: a phase i trial of ziftomenib combinations in kmt2a-rearranged or npm1-mutant aml
-
1:27
the role of menin inhibitors in the treatment of hr-mds and aml
-
2:41
israeli company on the edge of finding diabetes cure
-
7:46
updates in aml treatment and research from asco 2023
-
13:17
what should clinicians know about treating aml in 2023?
-
2:01
the future of menin inhibitors in aml
-
3:09
bleximenib combined with venetoclax and azacitidine in r/r aml with kmt2a or npm1 alterations
-
2:04
hot topics in the aml space: menin inhibitors
-
2:19
secondary-type mutations do not impact the favorable prognosis in npm1-mutated aml
-
6:32
a phase i trial of dsp-5336, a novel menin inhibitor, in the treatment of aml
-
1:12
phase i study of ziftomenib with venetoclax or venetoclax/azacitidine or 7 3 in r/r aml
-
5:24
safety by treatment phase and age when treating flt3-itd-mutated aml with quizartinib and chemo
-
2:43
venetoclax and intensive chemotherapy in npm1-mutated aml: findings from the caveat study
-
2:36
intensive induction chemotherapy vs hma/ven in npm1-mutant aml: a retrospective study
-
1:22
exciting upcoming mpns trials: v617f-targeted jak2 inhibitors and anti-calreticulin antibodies
-
2:09
advances in the management of fit adults with aml